Abstracts tagged "pain"

Abstract Number: 259 • 2014 ACR/ARHP Annual Meeting
Development of Pediatric Item Banks to Measure Pain Behavior in the Patient Reported Outcomes Measurement Information System
Esi M. Morgan DeWitt¹, Kimberly Barnett², Wen-Hung Chen³, Jennifer Farrell⁴, Dennis Revicki⁵, Adam Carle⁶, Karon Cook⁷, Kenneth Goldschneider⁸, Carlton Dampier⁹, David D. Sherry¹⁰ and Susmita Kashikar-Zuck², ¹Department of Pediatrics, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Evidera, Bethesda, MD, ⁴Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵Outcomes Research, Evidera, Bethesda, MD, ⁶Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁷Center for Patient-Centered Outcomes - Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁸Anesthesia, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁹Department of Pediatrics (Hematology-Oncology), Emory University School of Medicine, Atlanta, GA, ¹⁰Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA
Background/Purpose The NIH Patient Reported Outcomes Measurement Information System (PROMIS) has created publicly available patient reported outcomes measures in several domains of physical, social and…
Abstract Number: 255 • 2014 ACR/ARHP Annual Meeting
Pain As Predictor of Organ Involvement in Fabry Disease
Pierre Kaminsky¹, Frederic Barbey², Roland Jaussaud³, Francis Gaches⁴, Vanessa Leguy-Seguin⁵, Eric Hachulla⁶, Thierry Zenone⁷, Christian Lavigne⁸, Claire Douillard⁹, Isabelle Marie¹⁰, Boris Bienvenu¹¹, Bertrand Dussol¹² and Olivier Lidove¹³, ¹Internal Medicine, CHU Nancy, Vandoeuvre, France, ²CHU Vaudois, Lausanne, Switzerland, ³CHU de Reims, Reims, France, ⁴Hôpital Ducuing, Toulouse, France, ⁵CHU Dijon, Dijon, France, ⁶Medicine Interne et Oncologie Medicale Centre Pole, Lille University, Lille, France, ⁷CH de Valence, Valence, France, ⁸CHU d'Angers, Angers, France, ⁹CHU Lille, Lille, France, ¹⁰CHU de Rouen, Rouen, France, ¹¹Médecine interne, CHU Côte de Nacre, CAEN, France, ¹²AP Marseille, Marseille, France, ¹³Médecine interne, Hôpital Croix-Saint-Simon, PARIS, France
Background/Purpose Fabry disease (FD) in a X-linked hereditary lysosomal disorder due to alphagalactosidase A deficiency, leading to the accumulation of its substrate (globotriaosylceramide) in vessels,…
Abstract Number: 254 • 2014 ACR/ARHP Annual Meeting
The Effect of Milnacipran on Pain in Rheumatoid Arthritis Patients with Widespread Pain: a Randomized Blinded Crossover Trial
Yvonne C. Lee¹, Elena Massarotti², Robert R. Edwards³, Bing Lu⁴, Chih-Chin Liu⁵, Yuanyu Lo⁴, Alyssa Wohlfahrt⁴, Nancy Kim⁶, Daniel J. Clauw⁷ and Daniel H. Solomon⁸, ¹Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Rheumatology/PBB-3, Brigham & Women's Hosp, Boston, MA, ³Anesthesiology, Brigham & Womens Hospital, Chestnut Hill, MA, ⁴Brigham and Women's Hospital, Boston, MA, ⁵Rheumatology & Immunology, Brigham & Women's Hospital, Boston, MA, ⁶Div of Rheumatology, Massachusetts General Hospital, Charlestown, MA, ⁷Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI, ⁸Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Clinical trials have shown that serotonin norepinephrine reuptake inhibitors, such as milnacipran, decrease pain in chronic non-inflammatory pain conditions like fibromyalgia and osteoarthritis. We…
Abstract Number: 144 • 2014 ACR/ARHP Annual Meeting
Sonographic Differentiation of Heel Pain: Focal Degenerative Versus Systemic Inflammatory Enthesitis
Patrick Hook¹, Diana Vradii², Maureen Dubreuil^3,4, Hau Pham⁵ and Eugene Y. Kissin¹, ¹Rheumatology, Boston University School of Medicine, Boston, MA, ²Rheumatology, Mid Coast Hospital Medical Center, Brunswick, ME, ³Rheumatology, Boston University Medical Center, Boston, MA, ⁴Rheumatology, Boston VA HealthCare System, Boston, MA, ⁵Podiatry, Boston University Medical Center, Boston, MA
Background/Purpose: Plantar fasciitis and Achilles tendonitis are commonly encountered in a rheumatologic practice due to either degenerative (DG) or systemic inflammatory conditions (SYS). While…
Abstract Number: 253 • 2013 ACR/ARHP Annual Meeting
Higher Leg Extensor Muscle Power Output Is Associated With Reduced Pain and Better Quality Of Life In Patients With Symptomatic Knee Osteoarthritis
Kieran F. Reid¹, Lori Lyn Price², William F. Harvey³, Jeffrey B. Driban³, Roger A. Fielding¹ and Chenchen Wang³, ¹Nutrition, Exercise Physiology and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, ²Biostatistics Research Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, ³Rheumatology, Tufts Medical Center, Boston, MA
Background/Purpose: Muscle strength, the maximal force generating capacity of skeletal muscle, has been widely characterized in patients with knee osteoarthritis. However, skeletal muscle power, defined…
Abstract Number: 126 • 2013 ACR/ARHP Annual Meeting
Subgrouping Of Rheumatoid Arthritis Patients Based On Pain, Fatigue, Inflammation and Psychosocial Factors
Yvonne C. Lee¹, Michelle A. Frits¹, Christine K. Iannaccone¹, Michael E. Weinblatt¹, Nancy A. Shadick², David A. Williams³ and Jing Cui¹, ¹Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, ³Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI
Background/Purpose: Among rheumatoid arthritis (RA) patients, pain may be due to peripheral inflammation or other causes, such as central pain mechanisms. The objective was to…
Abstract Number: 2721 • 2013 ACR/ARHP Annual Meeting
Exercise Therapy and Ultrasound Guided Glucocorticoid Injection In Patients With Painful Shoulder: A Randomised Controlled Trial
Karen Ellegaard¹, Robin Christensen², Sara Rosager Mortensen¹, Cecilie Bartholby³, Søren Torp-Pedersen⁴, Thomas Bandholm⁵, Bente Danneskiold-Samsøe⁴, Henning Bliddal⁶ and Marius Henriksen⁷, ¹Department of rheumatology, Frederiksberg Hospital, The Parker Institute, Copenhagen, Denmark, ²Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, ³Department of rheumatology, Frederiksberg Hospital, The Parker Institute, Copenhangen, Denmark, ⁴Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, Frederiksberg, Denmark, ⁵Hvidovre Hospital, Copenhagen, Denmark, ⁶The Parker Institute, Copenhagen, Denmark, ⁷Department of Rheumatology, The Parker Institute, Copenhagen University Hospital at Frederiksberg, Copenhagen F, Denmark
Background/Purpose: SubAcromial Impingement (SAI) accounts for approximately 50% of all shoulder pain. The most commonly used treatments for SAI are glucocorticoid injection, exercise therapy or…
Abstract Number: 2308 • 2013 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Flares: Inflammatory Or Avalanche?
Caroline A. Flurey¹, Marianne Morris², Jon Pollock¹, Rodney A. Hughes³, Pamela Richards⁴ and Sarah Hewlett⁵, ¹Faculty of Health and Life Sciences, University of the West of England, Bristol, United Kingdom, ²University of the West of England, Bristol, United Kingdom, ³Rheumatology, St. Peters Hospital, Chertsey Surrey, United Kingdom, ⁴Academic Rheumatology Unit, University of Bristol, Bristol, United Kingdom, ⁵Academic Rheumatology, University of the West of England, Bristol, United Kingdom
Background/Purpose: Previous research has not addressed how RA patients' symptoms change daily. The aim of this study was to explore symptom patterns during daily life…
Abstract Number: 2250 • 2013 ACR/ARHP Annual Meeting
What Is The Real World Relationship Between Patient-Reported Pain Or Patient Global Assessment and Disease Activity Indices In Rheumatoid Arthritis? An Analysis From The Prospective, Observational, Biologic Treatment Registry Across Canada
Regan Arendse¹, Michael Starr², Proton Rahman³, John T. Kelsall⁴, Milton F. Baker⁵, William Bensen⁶, J. Carter Thorne⁷, Philip Baer⁸, Denis Choquette⁹, Isabelle Fortin¹⁰, Emmanouil Rampakakis¹¹, John S. Sampalis¹¹, Susan M. Otawa¹², May Shawi¹³, Francois Nantel¹⁴ and Allen J. Lehman¹², ¹University of Saskatchewan, Saskatoon, SK, Canada, ²Montreal General Hospital, Montreal, QC, Canada, ³Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, ⁴Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada, ⁵University of Victoria, Victoria, BC, Canada, ⁶St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, ⁷Southlake Regional Health Centre, Newmarket, ON, Canada, ⁸Private Practice, Scarborough, ON, Canada, ⁹Rheumatology, Institut de rhumatologie de Montréal (IRM), Montréal, QC, Canada, ¹⁰Centre de rhumatologie de l'est du Québec (CREQ), Rimouski, QC, Canada, ¹¹JSS Medical Research, Montreal, QC, Canada, ¹²Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹³Medical Affairs, Janssen Canada Inc, Toronto, ON, Canada, ¹⁴Janssen Inc., Toronto, ON, Canada
Background/Purpose: Patient-reported outcomes such as pain and patient global assessment of disease activity (PtGA) have been critiqued for not accurately assessing rheumatoid arthritis (RA) disease…
Abstract Number: 2161 • 2013 ACR/ARHP Annual Meeting
Biopsychosocial Typologies of Pain in a Cohort of Patients With Systemic Sclerosis
Erin L. Merz¹, Vanessa L. Malcarne¹, Shervin Assassi², Deepthi Nair², Tiffany Graham², Brayden Yellman², Rosa M. Estrada-Y-Martin³ and Maureen D. Mayes², ¹SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ²Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ³Pulmonary and Critical Care Medicine, University of Texas Health Science Center at Houston, Houston, TX
Background/Purpose: Despite being a common problem in Systemic Sclerosis, the extant literature on pain has primarily focused on biomedical correlates, or bivariate relationships with a…
Abstract Number: 2116 • 2013 ACR/ARHP Annual Meeting
Diabetes: A Risk Factor For Poor Function Outcome After Total Knee Arthroplasty
Jasvinder A. Singh^1,2 and David Lewallen³, ¹Rheumatology, Birmingham VA, Birmingham, AL, ²Department of Medicine, University of Alabama, Tuscaloosa, AL, ³Orthopedics, Mayo Clinic college of medicine, Rochester, MN
Background/Purpose: Previous studies have not provided any conclusive evidence whether patients with diabetes have worse patient-reported outcomes after joint replacement than patients without diabetes. Our objective…
Abstract Number: 2046 • 2013 ACR/ARHP Annual Meeting
Lower-Dose Indomethacin Submicron Particle Capsules’ Efficacy In Acute Pain: Results From Two Phase 3 Studies
Roy D. Altman¹, Allan Gibofsky², Mark Jaros³ and Clarence Young⁴, ¹David Geffen School of Medicine, UCLA, Los Angeles, CA, ²Medicine and Public Health, Hospital for Special Surgery, New York, NY, ³Summit Analytical, Denver, CO, ⁴Iroko Pharmaceuticals, Philadelphia, PA
Background/Purpose: Indomethacin is used to treat acute gouty arthritis and other acute pain conditions but, like other NSAIDs, is associated with dose-related gastrointestinal, cardiovascular, and…
Abstract Number: 2047 • 2013 ACR/ARHP Annual Meeting
Lower-Dose Indomethacin Submicron Particle Capsules’ Combined Safety From Two Phase 3 Studies In Patients With Acute Pain Following Elective Surgery
Allan Gibofsky¹, Roy D. Altman², Clarence Young³, Daniel Solorio⁴ and Jennifer Nezzer⁵, ¹Medicine and Public Health, Hospital for Special Surgery, New York, NY, ²David Geffen School of Medicine, UCLA, Los Angeles, CA, ³Iroko Pharmaceuticals, Philadelphia, PA, ⁴Iroko Pharmaceuticals, LLC, Philadelphia, PA, ⁵Premier Research, Philadelphia, PA
Background/Purpose: Indomethacin is prescribed to treat acute pain and inflammation but, like other NSAIDs, is associated with dose-dependent gastrointestinal, cardiovascular, and renal adverse events (AEs).…
Abstract Number: 1733 • 2013 ACR/ARHP Annual Meeting
Early and Sustained Improvement In Pain and Physical Function As Measured By Visual Analog Scale and Short Form-36 Physical Component Summary Score In Rheumatoid Arthritis Patients Treated With Mavrilimumab, An Investigational Anti-GM-CSFR-Alpha Monoclonal Antibody, In a Phase 2a Study
Gerd Burmester¹, Tsutomu Takeuchi², Olga Barbarash³, Duncan Porter⁴, Didier Saurigny⁵, David Close⁵, Alex Godwood⁵, Yoojung Yang⁶ and Ancilla W. Fernandes⁶, ¹Rheumatology and Clinical Immunology, Campus Mitte, Charite University Hospital, Berlin, Germany, ²Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, ³SIH Kemerovo Regional Clinical Hospital, Kemerovo, Russia, ⁴Rheumatology, Gartnavel General Hospital, Glasgow, United Kingdom, ⁵MedImmune, Ltd, Cambridge, United Kingdom, ⁶MedImmune, LLC, Gaithersburg, MD
Background/Purpose: Rheumatoid arthritis (RA) is associated with significant pain and loss of physical function. We evaluated self-reported pain and physical function in adults patients with…
Abstract Number: 751 • 2013 ACR/ARHP Annual Meeting
Fatigue, Pain, and Functional Disability Among Patients With Vasculitis
Antoine G. Sreih^1,2, Narender Annapureddy³ and Osama Elsallabi⁴, ¹Medicine/Division of Rheumatology, The University of Pennsylvania, Philadelphia, PA, ²Medicine/Rheumatology, Rush University Medical Center, Chicago, IL, ³Rheumatology, Rush University Medical Center, Chicago, IL, ⁴Medicine, Creighton University, Omaha, NE
Background/Purpose: Vasculitis is a heterogeneous group of diseases often resulting in severe morbidity affecting patients’ quality of life. These morbidities are generally attributed to disease…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].